DJIA 17,052.63 -45.82 -0.27%
NASDAQ 4,590.07 9.80 0.21%
S&P 500 2,000.17 -3.20 -0.16%
market minute promo

Celgene (NASDAQ: CELG)

94.91 -0.11 (-0.12%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

CELG $94.98 -0.04%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $95.50
Previous Close $95.02
Daily Range $94.70 - $96.44
52-Week Range $66.85 - $96.44
Market Cap $75.9B
P/E Ratio 54.92
Dividend (Yield) $0.00 (0.0%)
Volume 2,752,545
Average Daily Volume 4,053,252
Current FY EPS $3.18

Sector

Healthcare

Industry

Drugs

Celgene (CELG) Description

A biopharmaceutical company primarily engaged in the discovery, development and commercialization of innovative therapies designed to treat cancer and immune-inflammatory related diseases. Website: http://www.celgene.com/

News & Commentary

3 Reasons Celgene Corporation's Stock Could Fall

Celgene shares are up more than 1,200% over the past decade. But these three headwinds could be the brick wall that sends its stock lower.

Cramer: What's Working, What's Not

IBB, CELG, BIIB, ALXN: ETF Outflow Alert

Biotechnology, Oil And Brazil ETFs To Watch This Week

3 Stocks Reiterated As A Buy: HAL, CELG, CMCSA

Regeneron Pharmaceuticals' Pipeline Progress Raises Costs - Analyst Blog

Regeneron Pharmaceuticals' Pipeline Progress Raises Costs - Analyst Blog

Today's Market: Red Hot Biotech And Big Pharma Names To Watch

Bristol-Myers' Oral HCV Treatment Daklinza Gets EU Clearance - Analyst Blog

#PreMarket Primer: Thursday, August 28: Russia Implicated Further In Ukrainian Conflict

#PreMarket Primer: Thursday, August 28: Russia Implicated Further In Ukrainian Conflict

Biotech Stock Roundup: Biotechs Surge on InterMune Acquisition Deal, Focus on More M&As - Analyst Bl

Biotech Stock Roundup: Biotechs Surge on InterMune Acquisition Deal, Focus on More M&As - Analyst Blog

See More CELG News...

CELG's Top Competitors

CELG $94.91 (-0.12%)
Current stock: CELG
AMGN $137.32 (-1.48%)
Current stock: AMGN
GILD $108.61 (0.98%)
Current stock: GILD
$0.00 (0.00%)
Current stock: